STAT Plus: China’s biggest-ever Nasdaq biotech IPO comes at an awkward time
MARK LENNIHAN/AP
Legend’s Wall Street success arrives as a bipartisan group of lawmakers is pushing a bill that could force it and other companies off U.S. exchanges.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario